Skip to content
Open access

TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment

Sep 2026 · Journal of Experimental Medicine · Vol 223 · 1 citation · 60 references
Medicine

TL;DR

Evidence is provided for a key role of TNFR1, as expressed by malignant cells, in orchestrating a pro-tumor immunosuppressive environment through secondary inflammatory mediators through secondary inflammatory mediators.

Abstract

This study provides evidence for a key role of TNFR1, as expressed by malignant cells, in orchestrating a pro-tumor immunosuppressive environment through secondary inflammatory mediators. Results highlight the relevance of interfering TNFα/TNFR1 in cancer immunotherapy.

Read PDF

Similar papers

Open access Aug 2026

CD1d remodels the tumor-infiltrating myeloid populations controlling antitumor immunity

CD1d targeting reshapes tumor immune infiltrates, suppresses tumor growth, and enhances immunotherapy efficacy, suggesting an actionable pathway for therapeutic intervention.

Lauren Evans, Maria Conde Poole, Cenk Celik et al. · 0 citations
Aug 2026

CARM1: an epigenetic brake on cDC1-mediated antitumor immunity.

The underlying mechanism of tumor microenvironment-induced dysfunction of conventional type 1 dendritic cells (cDC1) remains unclear. Zhang et al. identify transforming growth factor β-driven coactivator-associated arginine methyltransferase 1 (CARM1) as an epigenetic inhibitor of cDC1 cross-presentation. CARM1 is a ce...

Congliang Chen, Xue-Tao Cao · 0 citations
Open access Sep 2026

STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma

It is reported that STAT3 inhibition eliminates multiple myeloma stem-like cells while eliciting hallmarks of immunogenic cell death, yet in vivo validation remains necessary before this strategy can be considered immunogenic.

O. Kepp, G. Kroemer · 0 citations
Review Open access Oct 2026

Genetic and Immunologic Interactions Driving STAT3 Signaling and Macrophage Polarization in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is an increasingly recognized malignancy sustained by a dysregulated inflammatory niche, in which genetic alterations and microenvironmental signaling converge to drive pathogenesis. This review synthesizes emerging evidence linking genetic mutations and immune dysregulation in AML, proposi...

K. O. Ahmed, M. A. Ahmed, G. Othman et al. · 0 citations
Sep 2026

Lactate suppresses STING activation to promote tumor immune evasion.

Lactate, known for its metabolic functions, has recently emerged as a signaling molecule. In a recent issue of Immunity, Guo and colleagues report that lactate is a competitive antagonist of STING and propose an epidermal growth factor receptor (EGFR)-mediated signaling cascade that enhances lactate dehydrogenase A (LD...

Yuan Tian, Xin Cai · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.